Pigmented nodular adrenocortical disease, primary, 1
MONDO:0012509Any primary pigmented nodular adrenocortical disease in which the cause of the disease is a mutation in the PRKAR1A gene.
Also known as: PRKAR1A primary pigmented nodular adrenocortical disease, pigmented nodular adrenocortical disease, primary, 1, pigmented nodular adrenocortical disease, primary, type 1, primary pigmented nodular adrenocortical disease caused by mutation in PRKAR1A, Cushing syndrome, adrenal, due to PPNAD1, PPNAD1, adrenocortical nodular dysplasia, primary, pigmented micronodular adrenocortical disease, primary, 1
9 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Researchers measure breathing, strength, and quality of life in hospitalized endocrine patients
Knowledge-focused CompletedThis completed observational study at Uşak University examined 150 adults hospitalized in the endocrinology department. Researchers measured breathing, muscle strength, pain, fatigue, sleep quality, physical activity, balance, and nerve function. The goal was to better understand…
Sponsor: Uşak University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Researchers track rare hormone disorder in 133 patients
Knowledge-focused CompletedThis study followed 133 people with PPNAD (a rare adrenal gland disorder) or Carney Complex (a related genetic condition) for three years. The goal was to better understand the symptoms and genetic causes of these diseases, not to test a new treatment. Participants had yearly che…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC